481 related articles for article (PubMed ID: 22053888)
1. Targeting the tumor microenvironment by immunotherapy: part 2.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment: part 1.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
[TBL] [Abstract][Full Text] [Related]
3. Tumor stroma-associated antigens for anti-cancer immunotherapy.
Hofmeister V; Vetter C; Schrama D; Bröcker EB; Becker JC
Cancer Immunol Immunother; 2006 May; 55(5):481-94. PubMed ID: 16220326
[TBL] [Abstract][Full Text] [Related]
4. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
5. Improving radioresponse through modification of the tumor immunological microenvironment.
Chi KH; Wang YS; Kao SJ
Cancer Biother Radiopharm; 2012 Feb; 27(1):6-11. PubMed ID: 22239431
[TBL] [Abstract][Full Text] [Related]
6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
7. [Development of novel immunotherapy targeting cancer immune evasion].
Tamada K
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
[TBL] [Abstract][Full Text] [Related]
8. Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment.
Shirota H; Klinman DM
Immunotherapy; 2013 Aug; 5(8):787-9. PubMed ID: 23902544
[No Abstract] [Full Text] [Related]
9. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
10. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
Bader JE; Voss K; Rathmell JC
Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive agents targeting tumor microenvironment.
Sharma SH; Thulasingam S; Nagarajan S
Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer therapies targeting the tumor stroma.
Hofmeister V; Schrama D; Becker JC
Cancer Immunol Immunother; 2008 Jan; 57(1):1-17. PubMed ID: 17661033
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and radiation.
Hiniker SM; Knox SJ
Semin Oncol; 2014 Dec; 41(6):702-13. PubMed ID: 25499631
[TBL] [Abstract][Full Text] [Related]
14. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Anari F; Ramamurthy C; Zibelman M
Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
[TBL] [Abstract][Full Text] [Related]
16. How to improve the immunogenicity of chemotherapy and radiotherapy.
Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L
Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323
[TBL] [Abstract][Full Text] [Related]
17. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
18. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
Ngambenjawong C; Gustafson HH; Pun SH
Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
[TBL] [Abstract][Full Text] [Related]
19. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
Harper J; Sainson RC
Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]